Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
In der Rubrik News haben wir 19748 Angebote für Sie gefunden
-
Global Vaccines & Vaccination Market Worth $769.4 Million by 2022 - Rising Use of Adjuvants in Vaccine-Preventable Diseases
30.06.2016Research and Markets has announced the addition of the "Global Vaccines & Vaccination Market Insights, Opportunity, Analysis, Market Shares and Forecast 2016 - 2022" report to their offering. The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $467 million in 2016 and is projected to reach up to $769.4 million by 2022. Increasing government investments and initiatives, rising company investments in vaccine development and increasing initiatives by non-government organizations become the major drivers.
-
Morphic Therapeutic Announces $51.5 Million Series A Financing to Develop Next-Generation Integrin Therapies
30.06.2016Morphic Therapeutic announced that it has completed a $51.5 million Series A financing to advance multiple programs into the clinic. Morphic Therapeutic was founded to translate advances from the laboratory of Timothy A. Springer, Ph.D., the Latham Family Professor at Harvard Medical School and Boston Children’s Hospital, into new therapies for immunological, fibrotic, neoplastic and vascular diseases. ...
-
US Pharmaceutical Industry Report 2016 - Research and Markets
30.06.2016Research and Markets has announced the addition of the "US Pharmaceutical Industry" report to their offering. "US Pharmaceutical Industry Report" covers a detailed research on the industry with product segments and process flow. It provides the typical value chain of a Pharmaceutical product using Biotechnology, break-up and details of the different markets, namely Oncology, Anti-Diabetes, Vaccines, etc. Investments in the Industry, Government Initiatives, Major Players and Future Outlook.
-
Cerus Corporation, the Transfusion Service of the Swiss Red Cross, and the University Hospital of Basel Receive a Grant of 2 Million Swiss Francs From the Swiss Red Cross Humanitarian Foundation for Whole Blood Pathogen Inactivation for Africa
30.06.2016Cerus, the Transfusion Service of the Swiss Red Cross, and the University Hospital of Basel Receive a Grant of 2 Million Swiss Francs from the Swiss Red Cross Humanitarian Foundation for Whole Blood. ...
-
Exosome Dx Enters Partnership with Takeda
30.06.2016Exosome Diagnostics, Inc., the world’s only provider of an exosome liquid biopsy platform to monitor disease biomarkers in patient blood, with the goal of reducing or eliminating the need for tissue biopsies, has entered into a collaboration with Takeda Pharmaceuticals International Co. to develop an exosomal RNA sequencing platform for biomarkers. ...
-
Funktionsweise von Pentagone entschlüsselt
30.06.2016Woher wissen die Zellen in einem menschlichen Embryo, wo sie sich im Körper befinden und wie sie sich entwickeln sollen? Warum bilden bestimmte Zellen einen Finger und andere nicht? Welche molekularen Mechanismen diese Schritte steuern, haben Freiburger Biologinnen und Biologen am Beispiel der Fruchtfliege entschlüsselt ...
-
Kinder sind gut für die Gesundheit
30.06.2016Arbeitnehmer mit Kindern sind nach einer Untersuchung der Techniker Krankenkasse (TK) seltener krankgeschrieben als Kinderlose und bekommen auch weniger Medikamente verschrieben. Im vergangenen Jahr waren Beschäftigte mit familienversicherten Kindern statistisch gesehen 2,3 Tage weniger krankgemeldet, ...
-
Sanner bringt seniorenfreundlichen Verschluss für Brausetablettenverpackungen auf den Markt
30.06.2016Die Sanner GmbH hat einen neuen Verschluss für Brausetablettenverpackungen entwickelt. Der neue FOG 27 Verschluss lässt sich in knapp einem Drittel der Zeit öffnen – und das mit 70 Prozent weniger Kraftaufwand im Vergleich zu herkömmlichen Verschlüssen.
-
Global AntiFungal Agents Market Worth $10.2 Million by 2022 - Rising Health Concerns Worldwide - Research and Markets
29.06.2016Research and Markets has announced the addition of the "Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022" report to their offering. The global antifungal agents market was estimated to grow around $10,200 million and it is expected to experience robust growth during 2016-2022. ...
-
eClinicalHealth Announces New Device-Independent Methodology for Validating ePRO Instruments
29.06.2016eClinicalHealth Limited has released a methodology to validate and standardize patient questionnaires across different data capture tools. With scientific support from ICON eCOA practice, eClinicalHealth’s methodology enables clinical trial participants to use their own electronic devices to record patient-reported outcomes while making it easier for researchers to ensure those devices are validated. ...
Sie sehen Artikel 19101 bis 19110 von insgesamt 19748
- Erste Seite
- 1909
- 1910
- 1911
- 1912
- 1913
- Letzte Seite
